Page 308 - merged
P. 308

Fig. 1. Figure 1: Significantly greater FA in schizophrenia  Fig. 2.Figure 2: Significantly lesser AD in schizophrenia
patients in comparison to healthy controls in multiple       patients in comparison to healthy controls in multiple
bilateral white matter tracts viz. superior and inferior     bilateral white matter tracts viz. superior and inferior
longitudinal fasciculi, corticospinal tract, corpus          longitudinal fasciculi, corticospinal tract, corpus
callosum, forceps major, forceps minor,                      callosum, forceps major, forceps minor,

Fig. 3.Figure 3: Significantly lesser RD in schizophrenia    Fig. 4.Figure 4: Significantly lesser MD in schizophrenia
patients in comparison to healthy controls in multiple       patients in comparison to healthy controls in multiple
bilateral white matter tracts viz. superior and inferior     bilateral white matter tracts viz. superior and inferior
longitudinal fasciculi, corticospinal tract, corpus          longitudinal fasciculi, corticospinal tract, corpus
callosum, forceps major, forceps minor,                      callosum, forceps major, forceps minor,

Fig. 5.Figure 5: Significantly greater FA in schizophrenia   Fig. 6.Figure 6: Significantly lesser RD in schizophrenia
patients at baseline compared to that at follow up in        patients at baseline compared to that at follow up in
multiple white matter tracts viz. bilateral superior and     multiple white matter tracts viz. right superior
inferior longitudinal fasciculi, bilateral corticospinal     longitudinal fasciculus, right corticospinal tract, corpus
tract, corpus callosum, forceps maj                          callosum, forceps minor, right anterior th

Reference: Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, et al. White matter
changes associated with antipsychotic treatment in first-episode psychosis.
Neuropsychopharmacology 2014. 39(6): p. 1324-31.
Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X, et al. White-matter microstructure in previously
drug-naive patients with schizophrenia after 6 weeks of treatment. Psychol Med 2013. 43(11): p.
2301-9.
   303   304   305   306   307   308   309   310   311   312   313